Patent · US Active

Measurement and comparison of immune diversity by high-throughput sequencing

US9909180B2 · kind B2 · utility

21Cited by
7References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2014
Grant dateMar 6, 2018
Priority date
Expiry dateApr 11, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

High-throughput long read sequencing is used to perform immunogenomic characterization of expressed antibody repertoires in the context of vaccination. Informatic analysis allows global characterizations of isotype distributions, determination of the lineage structure of the repertoire and measure age and antigen related mutational activity. Global analysis of the immune system's clonal structure provides direct insight into the effects of vaccination and provides a detailed molecular portrait of age-related effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.